DESIGN THERAPEUTICS INC
DSGNNASDAQ🏆 #2666 by market capEarnings Nov 3US Equity
$12.62▲ $0.27 (+2.10%)
🌙 After hours$12.62▲ 0.00%Regular close · extended-hours price shownTrack DSGN
Get earnings, price moves & breaking news on Telegram
24h▲ 2.1%
7d▲ 1.9%
14d▲ 0.9%
30d▼ 16.4%
ytd▲ 34.5%
1y▲ 66.4%
🏦Market Cap
$788M
Small Cap
📈Revenue Growth (YoY)
+0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
88
Very Good
DESIGN THERAPEUTICS INC
DSGNAnalyst Ratings
Price
$12.62
Total
7
Raised
3
Lowered
1
Avg PT
$20.50
H / L
$21 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Oppenheimer | Reiterated | Outperform | 2026-05-04 | $21.00 | +66.40% |
RBC Capital | Reiterated | Outperform | 2026-03-10 | $7.00 | −44.50% |
Leerink Partners | Upgraded | Market Perform → Outperform | 2025-12-03 | $14.00 | +10.90% |
Piper Sandler | Upgraded | Neutral → Overweight | 2024-05-07 | $20.00 | +58.50% |
Wedbush | Reiterated | Neutral | 2024-03-20 | — | — |
SVB Leerink | Downgraded | Outperform → Market Perform | 2023-08-15 | — | — |
Goldman Sachs | Upgraded | Sell → Neutral | 2023-05-04 | $10.00 | −20.80% |
Institution
Oppenheimer
Reiterated · Outperform · 2026-05-04
$21.00
+66.40%
RBC Capital
Reiterated · Outperform · 2026-03-10
$7.00
−44.50%
Leerink Partners
Upgraded · Market Perform → Outperform · 2025-12-03
$14.00
+10.90%
Piper Sandler
Upgraded · Neutral → Overweight · 2024-05-07
$20.00
+58.50%
Wedbush
Reiterated · Neutral · 2024-03-20
—
—
SVB Leerink
Downgraded · Outperform → Market Perform · 2023-08-15
—
—
Goldman Sachs
Upgraded · Sell → Neutral · 2023-05-04
$10.00
−20.80%
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space